http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-499044-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e00a330ce4c1e74ccd312f4e40e9ac81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 1937-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1939-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-499044-A
titleOfInvention Process for the manufacture of metallic iron for use as a pharmaceutical preparation
abstract Metallic iron powder for medical use is rendered more readily soluble in the gastric juices by bringing the particles into permanent contact with small proportions of platinum ruthenium, osmium, iridium or rhodium by depositing such metal by reduction on the metallic iron powder, or by reducing a compound of the metal simultaneously with a compound of iron. The specified metals have a lower hydrogen over-voltage than that of iron so that polarization by the hydrogen evolved on solution is reduced, and the iron dissolves more quickly and completely. The second metal is used in proportions of 0,1 to 1 per cent and is insufficient to form a complete coating on the iron particles. The powder may be made up in the form of tablets by coating with digestible material such as chocolate and malt, or doses of the powder may be provided with an air- and water-tight coating of an alcoholic solution of vegetable resins. According to examples: (1) reduced iron powder is added to an aqueous solution of platinic chloride, through which carbonic acid is passed, so that the platinium is deposited on the iron; (2) an acid solution of ferrous sulphate is mixed with a solution of platinum chloride, caustic soda is added, and the precipitate obtained is washed, dried, pulverized and reduced by heating in a current of hydrogen. Specification 386,499, [Group II], is referred to.ALSO:Metallic iron powder for medical use is rendered more readily soluble in the gastric juices by bringing the particles into permanent contact with small proportions of platinum, ruthenium, osmium, iridium or rhodium by depositing such metal by reduction on the metallic iron powder, or by reducing a compound of the metal simultaneously with a compound of iron. The specified metals have a lower hydrogen over-voltage than that of iron so that polarization by the hydrogen evolved on solution is reduced, and the iron dissolves more quickly and completely. The second metal is used in proportions of 0,1 to 1 per cent and is insufficient to form a complete coating on the iron particles. According to examples: (1) reduced iron powder is added to an aqueous solution of platinic chloride, through which carbonic acid is passed, so that the platinum is deposited on the iron; (2) an acid solution of ferrous sulphate is mixed with a solution of platinum chloride, caustic soda is added, and the precipitate obtained is washed, dried, pulverized and reduced to the metallic state by heating in a current of hydrogen. Specification 386,499 is referred to.
priorityDate 1937-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23619064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450184696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447773061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577470

Total number of triples: 36.